Mangaluru to get 15 smart CCTV cameras in sensitive places

Thiruvananthapuram, Mar 28: A man from Kerala was among the terrorists affiliated to Islamic State (IS) who allegedly attacked a Gurdwara in Kabul earlier this week in which 27 people were killed.

The IS has claimed that one of the suicide bombers was Abu Khalid al-Hindi.

According to sources, investigation agencies on Friday have identified him as 29-year-old Mohammed Sajid Kuthirummal of Padne in Kasargod. He was among the 14 persons, who left from Kerala to join IS in Nangarhar province of Afghanistan.

"IS had released the name Abu Khalid al-Hindi through its media agency soon after the attack. The photograph of him holding a rifle was also published by IS in their propaganda magazine Al Naba. From that, we have identified the person as Mohammed Sajid Kuthirummal. We are investigating the matter and in touch with the investigating agencies in Afghanistan for tracking his trail," sources told ANI.

The National Investigation Agency (NIA) probe had earlier revealed that Mohammed Sajid was recruited by Abdul Rashid Abdulla of Chandera, who was killed in Afghanistan last year.

Sajid worked as a shop keeper in a gulf country and returned to Kerala. Based on a complaint by Sajid's father Mahamood, the FIR was registered at Chendara Police Station, Kasaragod in 2016 regarding Sajid joining IS and leaving for Afghanistan.

He was among the 14 member team that left from Kerala to join IS in Khorasan Province' in Nangarhar.

ANI had earlier reported that two of these members Ayesha alias Sonia Sebastian and Fathima alias Nimisha who were in IS had expressed their interest in returning to Kerala. Out of 14, seven including Sajid is dead.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.

Bengaluru, Feb 9: The Karnataka Health and Family Welfare Services Department has kept 138 persons across the state under observation in the wake of novel coronavirus (nCov) scare, a health official said on Saturday.

"We are observing 138 people across the state, including in Bengaluru," the department's Communicable Diseases Wing Joint Director Prakash Kumar told news agency.

Though no coronavirus-positive case has been reported from Karnataka so far, four persons have been admitted in a state hospital under medical observation, Kumar confirmed.

Of the 104 samples sent for testing from the state, 85 have, so far, been declared negative. As many as 130 persons in the state were kept under home-isolation observation.

Four Karnataka districts bordering Kerala — Kodagu, Mangluru, Chamarajanagar and Mysuru — continue to be under surveillance after three positive coronavirus cases were reported in Kerala.

On Saturday, it was reported that three persons from Udupi were isolated at the Ajjarkad Government Hospital. Two of them had travelled to China while the other had returned to Udupi from Japan.

From January 20 till Saturday, 14,153 passengers underwent thermal screening at the Kempegowda International Airport, including three who had a history of visiting China’s Wuhan, the epicenter of the nCoV outbreak.

The '104 Arogya Sahayavani' call centre, which people can call for guidance on coronavirus, has clocked 1,792 calls so far.

"In case people with recent travel history to China and other affected countries develop any symptoms, they are requested to call 104 or health authorities and provide all necessary details in order to take necessary measures and are requested to be quarantined at home," reiterated the department.

Three confirmed cases of coronavirus were earlier reported in Kerala and over 722 deaths were confirmed around the world, mostly in mainland China.